These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26724331)

  • 1. On-rate based optimization of structure-kinetic relationship--surfing the kinetic map.
    Schoop A; Dey F
    Drug Discov Today Technol; 2015 Oct; 17():9-15. PubMed ID: 26724331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact, determination and prediction of drug-receptor residence times for GPCRs.
    Tautermann CS
    Curr Opin Pharmacol; 2016 Oct; 30():22-26. PubMed ID: 27428776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Target Binding Kinetics in Drug Discovery.
    Guo D; Heitman LH; IJzerman AP
    ChemMedChem; 2015 Nov; 10(11):1793-6. PubMed ID: 26506404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of thermodynamic and kinetic data in drug discovery: decisive insight or increasing the puzzlement?
    Klebe G
    ChemMedChem; 2015 Feb; 10(2):229-31. PubMed ID: 25537429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative variables in drug discovery: promises and challenges.
    Abad-Zapatero C; Champness EJ; Segall MD
    Future Med Chem; 2014 Apr; 6(5):577-93. PubMed ID: 24649959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic binding assays for the analysis of protein-ligand interactions.
    Meyer-Almes FJ
    Drug Discov Today Technol; 2015 Oct; 17():1-8. PubMed ID: 26724330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of binding kinetics in therapeutically useful drug action.
    Swinney DC
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):31-9. PubMed ID: 19152211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational modeling approaches to quantitative structure-binding kinetics relationships in drug discovery.
    De Benedetti PG; Fanelli F
    Drug Discov Today; 2018 Jul; 23(7):1396-1406. PubMed ID: 29574212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of drug-target residence time.
    Zhang R; Monsma F
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):488-96. PubMed ID: 19562645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
    Edwards PJ; Allart B; Andrews MJ; Clase JA; Menet C
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):425-44. PubMed ID: 16889227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants of drug-receptor binding kinetics.
    Pan AC; Borhani DW; Dror RO; Shaw DE
    Drug Discov Today; 2013 Jul; 18(13-14):667-73. PubMed ID: 23454741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologation: A Versatile Molecular Modification Strategy to Drug Discovery.
    Lima LM; Alves MA; do Amaral DN
    Curr Top Med Chem; 2019; 19(19):1734-1750. PubMed ID: 31393250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target identification of covalently binding drugs by activity-based protein profiling (ABPP).
    Pichler CM; Krysiak J; Breinbauer R
    Bioorg Med Chem; 2016 Aug; 24(15):3291-303. PubMed ID: 27085673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel High-Throughput FLIPR Tetra-Based Method for Capturing Highly Confluent Kinetic Data for Structure-Kinetic Relationship Guided Early Drug Discovery.
    Khurana P; McWilliams L; Wingfield J; Barratt D; Srinivasan B
    SLAS Discov; 2021 Jun; 26(5):684-697. PubMed ID: 33783249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and the drug-target residence time concept.
    Dahl G; Akerud T
    Drug Discov Today; 2013 Aug; 18(15-16):697-707. PubMed ID: 23500610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lipophilic efficiency on compound quality.
    Tarcsay A; Nyíri K; Keseru GM
    J Med Chem; 2012 Feb; 55(3):1252-60. PubMed ID: 22229549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes.
    Mortier J; Rakers C; Bermudez M; Murgueitio MS; Riniker S; Wolber G
    Drug Discov Today; 2015 Jun; 20(6):686-702. PubMed ID: 25615716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.